​

Elicio Therapeutics Ownership | Who Owns Elicio Therapeutics?

OverviewFinancialsChart

Elicio Therapeutics Ownership Summary

Elicio Therapeutics is owned by 6.35% institutional investors, 36.77% insiders, and 56.88% retail investors. Knoll capital management is the largest institutional shareholder, holding 3.93% of ELTX shares.

ELTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockElicio Therapeutics6.35%36.77%56.88%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Knoll capital management630.91K3.93%$6.90M
Vanguard group496.90K2.98%$3.96M
Geode capital management132.52K0.79%$1.06M
Marshall wace, llp86.53K0.54%$946.67K
Northern trust53.58K0.33%$586.21K
Blackrock funding, inc. /de45.18K0.27%$359.63K
State street38.30K0.24%$419.00K
Ubs group32.02K0.19%$254.85K
Renaissance28.11K0.17%$223.76K
Cresset asset management26.93K0.17%$294.56K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knoll capital management630.91K3.70%$6.90M
Cm management25.00K0.17%$199.00K
Mayflower financial advisors10.00K0.01%$79.60K
Moody lynn & lieberson10.00K0.00%$79.60K
Meyer handelman13.90K0.00%$110.64K
Summit financial10.01K0.00%$79.68K
Cresset asset management26.93K0.00%$294.56K
Marshall wace, llp86.53K0.00%$946.67K
Wiley bros.-aintree capital10.00K0.00%$109.40K
Jefferies financial group11.94K0.00%$95.06K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp86.53K0.00%86.53K
Cresset asset management26.93K0.00%26.93K
Ubs group32.02K-25.00K
Vanguard group496.90K0.00%23.04K
Cm management25.00K0.17%19.00K

Top Sellers

HolderShares% AssetsChange
Hudson bay capital management lp---182.73K
Renaissance28.11K0.00%-20.56K
Quantinno capital management lp---20.00K
Jane street group---14.99K
Citigroup---10.66K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp86.53K0.00%86.53K$946.67K
Cresset asset management26.93K0.00%26.93K$294.56K
Hightower advisors11.19K0.00%11.19K$89.04K
Summit financial10.01K0.00%10.01K$79.68K
Group one trading323.00-323.00$2.57K

Sold Out

HolderChange
Jpmorgan chase-16.00
Simplex trading-103.00
Raymond james financial-6.00K
Citigroup-10.66K
Jane street group-14.99K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202525-21.88%1,060,602-45.42%64.34%16-20.00%2-
Sep 30, 20253134.78%1,936,27333.46%1214.77%20100.00%2-60.00%
Jun 30, 202523-4.17%1,450,816-8.85%95.98%10-41.18%5150.00%
Mar 31, 20252441.18%1,591,744250.55%1288.77%17325.00%2-66.67%
Dec 31, 202417-5.56%454,072-7.61%328.42%4-60.00%6500.00%

Recent Insider Transactions

DateNameRoleActivityValue
Aug 12, 2024Chudnovsky Yekaterina Buy$20.00M
Jun 28, 2024Venkatesan Jay-Buy$250.00K
Jun 28, 2024Venkatesan Jay-Buy$500.00
Jun 28, 2024Chudnovsky Yekaterina Buy$8.00M
Jun 28, 2024Chudnovsky Yekaterina Buy$16.00K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q4--

ELTX Ownership FAQ

Who Owns Elicio Therapeutics?

Elicio Therapeutics shareholders are primarily institutional investors at 6.35%, followed by 36.77% insiders and 56.88% retail investors. The average institutional ownership in Elicio Therapeutics's industry, Biotech Stocks , is 382.11%, which Elicio Therapeutics falls below.

Who owns the most shares of Elicio Therapeutics?

Elicio Therapeutics’s largest shareholders are Knoll capital management (630.92K shares, 3.93%), Vanguard group (496.9K shares, 2.98%), and Geode capital management (132.52K shares, 0.79%). Together, they hold 7.70% of Elicio Therapeutics’s total shares outstanding.

Does Blackrock own Elicio Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Elicio Therapeutics.

Who is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.70% of its assets in 630.92K Elicio Therapeutics shares, valued at 6.9M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools